|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/46 | |||
| C12N 15/85 |
| (11) | Number of the document | 2951207 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14706169.1 |
| Date of filing the European patent application | 2014-01-31 | |
| (97) | Date of publication of the European application | 2015-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/014175 |
| Date | 2014-01-31 |
| (87) | Number | WO 2014/121087 |
| Date | 2014-08-07 |
| (30) | Number | Date | Country code |
| 201361759578 P | 2013-02-01 | US |
| (72) |
DAVIS, Samuel, US
SMITH, Eric, US
PATEL,Supriya, US
RAFIQUE, Ashique, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTIBODIES COMPRISING CHIMERIC CONSTANT DOMAINS |
| ANTIBODIES COMPRISING CHIMERIC CONSTANT DOMAINS |